Post-approval studies (Phase 4)Not Yet RecruitingNCT06974344
What this trial is testing
Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial)
Who this might be right for
Small-for-Size Syndrome
King Faisal Specialist Hospital & Research Center 80